Veeva has identified three key actions that enable biopharmaceutical companies to develop an “Agentic Commercial” advantage in their operations. The company positions these actions as strategic approaches for pharma businesses to enhance their commercial capabilities and competitive positioning. The specific details of these three actions were outlined in Veeva’s analysis targeting the biopharma sector.